Abstract It is know that repeated exposure to opiates impairs spatial learning and memory and that the hippocampus has important neuromodulatory effects after drug exposure and withdrawal symptoms. Thus, the aim of this investigation was to assess hippocampal levels of BDNF, oxidative stress markers associated with cell viability, and TNF-a in the short, medium and long term after repeated morphine treatment in early life. Newborn male Wistar rats received subcutaneous injections of morphine (morphine group) or saline (control group), 5 lg in the mid-scapular area, starting on postnatal day 8 (P8), once daily for 7 days, and neurochemical parameters were assessed in the hippocampus on postnatal days 16 (P16), 30 (P30), and 60 (P60). For the first time, we observed that morphine treatment in early life modulates BDNF levels in the medium and long term and also modulates superoxide dismutase activity in the long term. In addition, it was observed effect of treatment and age in TNF-a levels, and no effects in lactate dehydrogenase levels, or cell viability. These findings show that repeated morphine treatment in the neonatal period can lead to long-lasting neurochemical changes in the hippocampus of male rats, and indicate the importance of cellular and intracellular adaptations in the hippocampus after early-life opioid exposure to tolerance, withdrawal and addiction. 
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Introduction
Morphine has been widely used in ventilated neonates because of its potent analgesic effect, prolonged duration of action, and relatively low potential for tolerance [1, 2] . Evidence suggests that the tolerance to repeated injections of morphine in pups is less pronounced than in adults, since this tolerance could be masked by several processes [3] . In addition, our group showed that animals submitted to repeated morphine exposure in early life (5 lg sc/dia/7dias from P8) did not developed to classic opioid tolerance, and they presented longer analgesia duration at P14 that was observed at least until P80 [4] . These results also agree with another study that suggests that the development of opioid system occurs within the first 2 weeks of life [5] . Thus, there are increasing concerns that opiates may have detrimental effects on neurodevelopment outcomes. Therefore, it is important to understand the effects of chronic opiate exposure on the immature body. Studies have shown that prolonged exposure to opiates in the adult rat produces distinct biochemical and physiological changes in neurons and in entire interacting circuits of neurons, which, in turn, can result in long-term alterations in cellular communication [6] [7] [8] [9] . The opioid exposure can decrease spine density, neurogenesis, and alter synaptic transmission in the hippocampus [10] [11] [12] [13] . In contrast, other studies show that opioids can modulate some processes in the hippocampal formation, including adult neurogenesis and development of neonatal transmitter systems [14] . Prolonged exposure to opiates also reduces hippocampal long-term potentiation (LTP) [15, 16] which is related to spatial learning and memory prejudice [17] . On the other hand, our group has shown that exposure of newborn rats to morphine alters nociceptive parameters until adult life [4, 18] and affects some exploratory and anxiolytic-like behaviours in the short and medium term (Rozisky et al., personal communication) . These effects are possibly related to drug withdrawal. At a cellular level, other researchers have shown that morphine treatment in the neonatal period alters gene expression in the hippocampus [19] and its cellular composition [20] , producing long-term neurobehavioral deficits in rodents [21, 22] . In addition, exposure of rats to this drug in the postnatal period and adult life has also been associated with generation of free radicals due to an imbalance between high cellular levels of reactive oxygen and nitrogen species (ROS and RNS) and cellular antioxidant defences, namely oxidative stress [23, 24] . Both reactive species can induce mitochondrial dysfunction [25] , damage neuronal precursors and impair neurogenesis [26] . A consequence of the production of ROS is induction of biosynthesis of pro-inflammatory cytokines, such as tumour necrosis factor alpha (TNF-a), suggesting a complex interplay between CNS inflammation and oxidative stress [27] .
Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, is widely expressed in the developing central and peripheral nervous system [28, 29] , and in high levels in the hippocampus [30] . After binding to the TrkB (tyrosine kinase B receptor) on the cell surface of neurons, BDNF regulates neuronal survival, promotes neurite outgrowth, and maintains synaptic connectivity in the adult nervous system [31] . Other studies have reported neuromodulatory effects of BDNF on learning and memory, depression [32] , and drug addiction [33] [34] [35] . There is evidence that BDNF plays a significant role in brain effects, such as synaptic plasticity [36] and locomotor sensitization [37] after opioid withdrawal.
Considering the dearth of studies on the neurochemical effects of neonatal morphine exposure and the involvement of the hippocampus in neuroplasticity process after drug exposure, the aim of this study was to verify whether repeated morphine administration in early life alters hippocampal BDNF and TNF-a levels, as well as oxidative stress markers and the susceptibility to H 2 O 2 -induced oxidative damage in hippocampal slices.
Methods

Animals
Animals and Housing Conditions
Neonate male Wistar rats, 8-day-old at the beginning of the experiment, were used. They were in home cages made of polypropylene (49 9 34 9 16 cm) with the floor covered with sawdust, with their mothers, maintained on a standard 12-h dark/light cycle (lights on at 07:00 a.m. and lights off at 07:00 p.m.) at room temperature (22 ± 2°C). The animals had free access to food and water. All experiments in this study were conducted in male rats because the nociceptive process and drug responses are altered by modulations in hormone state [38] . At birth, the male litters were standardized in according Silveira et al. [39, 40] with minor modifications, containing 8 male pups per dam. Studies that assesses the development of offspring during lactation, is the current procedure of adjustment litter in the first days of birth in order to homogenization nutritional conditions for all puppies [41] . Infant rats (at P8) were divided into two groups: saline control (C) and morphine-treated (M). Rats at P8 were chosen because it is accepted that animals of this age have a similar neurological development to that of a human newborn [42] . These animals are in a physiologically immature state [43] since this period is characterized by major developmental changes in the brain and plasticity of the developing pain system [44] [45] [46] .
Several reports suggest that the ability to induce longterm potentiation in area CA1 of hipocampal slices appears between the first and second week after birth [47, 48] . In the neonatal hippocampus, glutamatergic LTP is not readily observed until P14 [48, 49] and LTD has not been revealed earlier than P6 [49] [50] [51] .
At 21 days of age, the animals were separated from their mothers. Animal handling and all experiments were performed in accordance with Brazilian Law No. 11.794 of October 8, 2008 , on the use of animals for scientific research, and performed in accordance with the Guide for the Care and Use of Laboratory Animals 8th edition (2011). All experiments and procedures were approved by the Institutional Committee for Animal Care and Use (GPPG-HCPA protocol No. 08345). And, measures were taken to minimize animal pain and discomfort. The experiment used the minimum number of animals required to produce reliable scientific data.
Drug Administration
Each animal received saline (control group) or morphine (5 lg s.c. in the mid-scapular area; morphine group) starting at P8, then once daily for 7 days. This dose was chosen on the basis of previous studies by our research group [4, 18, [52] [53] [54] , and is known to produce analgesia in all animals subjected to the tail-flick test. All treatments were administered at the same time each day (11.00 h). One millilitre of morphine sulfate was diluted in 9 ml of 0.9 % NaCl (normal saline solution). After 2 days (P16), 2 weeks (P30) and 6 weeks (P60) of the end of treatment, the rats were decapitated and their hippocampi were rapidly dissected out for cell viability analysis or stored at -70°C until BDNF and TNF-a assays and analysis of oxidative stress parameters. The assays were performed at P16 (n = 4-5/group/assay of rats), P30 (n = 5-7/group/ assay of rats), and P60 (n = 4-5/group/assay of rats).
Morphine sulfate (Dimorf Ò 10 mg/ml, Cristália Ltda., São Paulo, Brazil) and other chemicals were provided by Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Analysis of BDNF Immunocontent BDNF levels were determined by enzyme-linked immunosorbent assay (ELISA) using the ChemiKine kit (Millipore), according to manufacturer recommendations. Briefly, hippocampi were individually homogenised (1:10 w/v) in a lysis buffer containing 1 M NaCl, 100 mM Tris-HCl (pH 7.0), 4 mM disodium edetate, 2 % Triton X-100, and the protease inhibitors (Sigma) aprotinin (5 lg/mL), antipain (0.5 lg/mL), benzamidine (157 lg/mL), pepstatin A (0.1 lg/mL), and phenylmethanesulfonyl fluoride (PMSF, 17 lg/ mL). Homogenates were centrifuged at 14,0009g for 30 min at 4°C. The resulting supernatants were used for the BDNF assay. Samples were incubated on 96-well flat bottom plates previously coated with anti-BDNF polyclonal antibody at 2-8°C overnight. After this first incubation, biotinylated mouse anti-BDNF monoclonal antibody was added to each well and incubated for 2-3 h and streptavidinhorseradish peroxidase conjugate for 1 h. TMB/E Substrate was added to each well for 15 min until the 500 pg/mL standard reached a deep blue colour. The reaction was stopped by addition of stop solution (HCl) to each well, the blue colour changing to yellow. The colour reaction was quantified immediately by spectrophotometry in a plate reader at 450 nm. The standard BDNF curve was performed on each plate, ranging from 0 to 500 pg/mL.
Analysis of TNF-a Immunocontent
The analysis of TNF-a in hippocampus homogenates was performed only at the ages where there were significant differences in BDNF levels (P30 and P60). TNF-a level was determined with a commercially available enzyme-linked immunosorbent assay (ELISA) kit for rat TNF-a (Uscn, Life Science Inc.), according to manufacturer protocols. Briefly, hippocampi were individually homogenised (1:10 w/v) in phosphate buffered saline (PBS). The homogenates were centrifuged at 5,0009g for 5 min at 4°C. The resulting supernatants were used for the TNF-a assay. Samples were incubated on 96-well flat bottom plates previously coated with anti-TNF-a antibody for 2 h at 37°C. After this first incubation, a TNF biotin-conjugated antibody preparation specific for TNF-a was added to each well and incubated for 1 h and avidin-conjugated horseradish peroxidase for 30 min at 37°C. TMB/E Substrate was added to each well for 15-25 min at 37°C until the 1,000 pg/mL standard reached a deep blue colour. The reaction was stopped by addition of stop solution (H 2 SO 4 ) to each well (the blue colour changing to yellow). The colour reaction was quantified immediately by spectrophotometry in a plate reader at 450 nm. The standard TNF-a curve was performed on each plate, ranging from 0 to 1,000 pg/mL.
Assessment of Oxidative Stress Parameters
Structures were thawed and homogenised in 10 vol (w/v) ice-cold 50 mM potassium phosphate buffer (pH 7.4), containing 1 mM EDTA. The homogenate was centrifuged at 1,0009g for 10 min at 4°C and the supernatant was used for assays of oxidative stress.
Superoxide Dismutase Activity
Superoxide dismutase (SOD) activity was determined using the RANSOD kit (Randox Labs, USA), which is based on the procedure described by Delmas-Beauvieux [55] . This method employs xanthine and xanthine oxidase to generate superoxide radicals that react with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride (INT) to form a formazan dye that is assayed spectrophotometrically at 492 nm at 37°C. The inhibition in chromogen production is proportional to the activity of SOD present in the sample; one unit of SOD causes 50 % inhibition of the rate of INT reduction under the conditions of the assay.
Glutathione Peroxidase Activity
Glutathione peroxidase (GPx) activity was determined as described by Wendel [56] , with some modifications. The reaction was carried out at 37°C in a solution containing 20 mM potassium phosphate buffer (pH 7.7), 1.1 mM EDTA, 0.44 mM sodium azide, 0.5 mM NADPH, 2 mM glutathione, and 0.4 U glutathione reductase. GPx activity was measured with tert-butylhydroperoxide as the substrate at 340 nm. The contribution of spontaneous NADPH oxidation was always subtracted from the overall reaction ratio. GPx activity was expressed as nmol of NADPH oxidized per minute per mg of protein.
Evaluation of Reactive Species Production by Chemical Oxidation of Dichlorodihydrofluorescein (DCFH)
Samples were incubated with 2 0 ,7 0 -dichlorodihydrofluorescein diacetate (100 lM) at 37°C for 30 min. The formation of the oxidized fluorescent derivative dichlorofluorescein (DCF) was monitored by excitation and emission wavelengths of 488 and 525 nm respectively, using a SpectraMax M5 plate reader. The formation of reactive oxygen/nitrogen species was quantified using a DCF standard curve and results were expressed as nmol of DCF formed per mg of protein [57] .
Determination of Total Thiol
This assay is based on the reduction of 5,5 0 -dithiobis(2-nitrobenzoic acid) (DTNB) by thiol groups, which becomes oxidized (disulfide), yielding a yellow compound (2-nitro-5-thiobenzoic acid, TNB) whose absorption is measured spectrophotometrically at 412 nm. The sulfhydryl content is inversely correlated to oxidative damage to proteins. Results were reported as nmol of TNB per mg of protein [58] .
Preparation of Hippocampal Slices and Susceptibility to H 2 O 2 -Induced Cell Damage Rats were killed by decapitation on postnatal days 16 (P16), 30 (P30) and 60 (P60), and hippocampi were quickly dissected out and transverse sections (400 lm) prepared using a McIlwain tissue chopper. Slices of the hippocampus of each animal were divided in two sets (control condition and in vitro H 2 O 2 -induced injury), placed into separate 24-well culture plates and pre-incubated for 30 min in a medium with the following composition: 120 mM NaCl, 2 mM KCl, 1 mM CaCl 2 , 1 mM MgSO 4 , 25 mM HEPES, 1 mM KH 2 PO 4 , and 10 mM glucose, adjusted to pH 7.4. After preincubation, the medium in the control plate was replaced with another medium solution and incubated for 60 min at 37°C.
In the H 2 O 2 -induced injury plate, the medium was changed and 1 mM H 2 O 2 was added for 60 min at 37°. The control and H 2 O 2 experiments were run concomitantly, using four slices of the same animal in each plate [59] . At the end of the recovery period, cellular viability (mitochondrial activity) and cellular damage (membrane lyses) were evaluated.
Cellular Damage
Cellular damage was quantified by measuring lactate dehydrogenase (LDH) released into the culture medium (lacking serum) [60] . After the recovery period, LDH activity was determined using a commercially available kit (Doles Reagents, Goiania, Brazil). Each experiment was normalized by subtracting the background levels of LDH produced from the control wells. Samples were quantified using a standard curve; the optical density was measured at 490 nm. Results were expressed as percentage of control.
Cellular Viability
Mitochondrial activity was evaluated by the colorimetric MTT [3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (Sigma Chemicals) method. Hippocampal slices were incubated for 30 min at 37°C in the presence of MTT (5 mg/ml). Active mitochondrial dehydrogenases of living cells cause cleavage and reduction of the soluble yellow MTT dye to insoluble purple formazan, which was extracted in dimethyl sulfoxide (DMSO); the optical density was Neurochem Res (2013) 38:494-503 497 measured at 560 and 630 nm [61] . Results were expressed as percentage of control.
Protein Assay
Total protein concentration was determined using the Lowry method [62] , with bovine serum albumin as the standard.
Statistical Analysis
The results were expressed as the mean ± standard error of the mean (S.E.M.). The data analysis and interactions were evaluated using two-way ANOVA (morphine, age, morphine*age) followed by the Student-Newman-Keuls (SNK) method when indicated. The between group differences were considered significant at P \ 0.05.
Results
Hippocampal BDNF and TNF-a Levels After Morphine Exposure in Early Life
The two way ANOVA showed no effect of age (P = 0.327). However, there is effect of morphine (P = 0.042), and interaction between age and morphine treatment (P = 0.049) in BDNF levels ( Fig. 1 Panel A) .
In the TNF-a levels, the two way ANOVA showed effects of age (P = 0.036), of morphine treatment (P = 0.011), and no interaction between age and morphine treatment (P = 0.275) (Fig. 1 Panel B) . TNF-a levels were analyzed only at the ages where differences in BDNF were observed (i.e. P30 and P60).
Antioxidant Enzyme Activities, Total Thiol Levels, and Reactive Species Production in the Hippocampus After Morphine Exposure in Early Life Table 1 shows oxidative stress parameters after morphine exposure in newborn rats, from P8 through P14, analyzed at the short (P16), medium (P30), and long term (P60). There is effect of morphine treatment (P = 0.01), however it was not observed effect of age (P = 0.127) and no interaction between age and morphine treatment in the SOD activity (P = 0.144) (two way ANOVA for all).
In the GPx activity, it was observed effect of age (P \ 0.001), no effects of morphine treatment (P = 0.624) and no interactions between age and morphine treatment (P = 0.164) (two way ANOVA for all).
In the thiol levels was also observed effect of age (P = 0.041), no effects of morphine treatment (P = 0.178) and no interactions between age and morphine treatment (P = 0.254) (two way ANOVA for all).
In the analysis of reactive species production (by DCF technique) were observed effect of age (P \ 0.001), no effects of morphine treatment (P = 0.541) and no interactions between age and morphine treatment (P = 0.715) (two way ANOVA for all).
In the SOD/GPx ratio was observed effect of age (P = 0.031), effect of treatment (P = 0.033) and marginal interactions between age and morphine treatment (P = 0.06) (two way ANOVA for all).
Susceptibility to Oxidative Damage in Hippocampal Slices After Morphine Exposure in Early Life
In order to analyse the effect of morphine treatment in early life on H 2 O 2 -induced injury, we employed LDH released into the media as a marker of cell damage or lysis, Fig. 1 Effect of morphine administration in early life on TNF-a and BDNF levels at postnatal days 16, 30 and 60. There is effect of morphine (P = 0.042), interaction between age and morphine treatment (P = 0.049), and no effect of age (P = 0.327) in BDNF levels (a). In the TNF-a levels, there are effects of age (P = 0.036), of morphine treatment (P = 0.011), and no interaction between age and morphine treatment (P = 0.275) (b). TNF-a levels were analyzed only at the ages where differences in BDNF were observed (i.e. P30 and P60). The data analysis and interactions were evaluated using two-way ANOVA followed by Bonferroni's method. Bars represent mean ± SEM. BDNF (a) and TNF-a (b) levels are expressed as pg mL -1 of hippocampus tissue homogenates. Abbreviations: BDNF, brain-derived neurotrophic factor; TNF-a, tumour necrosis factor alpha and reduction of the soluble yellow MTT dye as a marker of living cells. Table 2 shows cell damage (expressed by released LDH) and cellular viability (measured by the MTT assay) H 2 O 2 -induced injury cell at P16, P30 and P60. In the MTT assay, there are no interactions between age and morphine treatment and H 2 O 2 -induced cellular damage (P = 0.887), morphine and age (P = 0.880), morphine and H 2 O 2 -induced cellular damage (P = 0.200), and morphine treatment (P = 0.526) (two way ANOVA for all). However, the adjustment for multiple comparisons (Bonferroni's test) showed an effect of H 2 O 2 -induced cellular damage (P \ 0.001), interaction between age and H 2 O 2 -induced cellular damage (P = 0.034), and effect of age showed significant difference between P16 and P60 (P = 0.009).
The following results were observed for LDH analysis: there are no interactions between age and morphine treatment and H 2 O 2 -induced cellular damage (P = 0.303), between age and H 2 O 2 -induced cellular damage (P = 0.502), and morphine treatment and H 2 O 2 -induced cellular damage (P = 0.664), and not effects of age (P = 0.433) and of morphine treatment (P = 0.611) (two way ANOVA for all). However, the adjustment for multiple comparisons (Bonferroni's test) showed effect of H 2 O 2 -induced cellular damage (P \ 0.001). There is effect of morphine treatment (P = 0.01), no effect of age (P = 0.127) and no interaction between age and morphine treatment in the SOD activity (P = 0.144); effect of age (P \ 0.001), no effects of morphine treatment (P = 0.624) and no interactions between age and morphine treatment in the GPx activity (P = 0.164); in the thiol levels was also observed effect of age (P = 0.041), no effects of morphine treatment (P = 0.178) and no interactions between age and morphine treatment (P = 0.254); there is effect of age (P \ 0.001), no effects of treatment (P = 0.541) and no interactions between age and morphine treatment in the analysis of reactive species production (P = 0.715). In the SOD/GPx ratio was observed effect of age (P = 0.031), effect of treatment (P = 0.033) and marginal interactions between age and morphine treatment (P = 0.06). The data analysis and interactions were evaluated using two-way ANOVA followed by Bonferroni's method. The results are expressed as the mean ± S.E.M. Abbreviations: SOD, superoxide dismutase; GPx, glutathione peroxidase In the MTT assay, there are no interactions between age and morphine treatment and H 2 O 2 -induced cellular damage (P = 0.887), between morphine and age (P = 0.880) and between morphine and H 2 O 2 -induced cellular damage (P = 0.200). However, there is effect of H 2 O 2 -induced cellular damage (P \ 0.001), and interaction between age and H 2 O 2 -induced cellular damage (P = 0.034), and no effect of morphine treatment (P = 0.526). There is significant difference between P16 and P60 (P = 0.009). In the LDH assay, there are no interactions between age and morphine treatment and H 2 O 2 -induced cellular damage (P = 0.303), between age and H 2 O 2 -induced cellular damage (P = 0.502), and morphine treatment and H 2 O 2 -induced cellular damage (P = 0.664). However, there is effect of H 2 O 2 -induced cellular damage (P \ 0.001), but there are not effects of age (P = 0.433) and morphine treatment (P = 0.611). The data analysis and interactions were evaluated using two-way ANOVA followed by Bonferroni's method. The results are expressed as percentage of MTT reduced or LDH released obtained on control group, which is considered as 100 %. Abbreviations: MTT, 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; LDH, lactate dehydrogenase Neurochem Res (2013) 38:494-503 499
Discussion
In this study, we showed that morphine treatment in newborn rats alters BDNF levels and oxidative stress markers in the hippocampus, finding, for the first time, that morphine treatment in early life modulates BDNF levels by age. Furthermore, neonatal morphine exposure negatively modulates superoxide dismutase activity. It bears stressing that this finding-and the parallel modulation in SOD/GPx activity ratio may lead to lower concentrations of H 2 O 2 , as this ratio has been used as a marker of peroxide overload challenge [63] . In addition, were observed effect of treatment and age in levels of the pro-inflammatory cytokine TNF-a. On the other hand, we observed that both the control and morphine groups exhibited hippocampal oxidative damage after exposure to H 2 O 2 in both ages analyzed under the conditions of this study. A previous study demonstrated that BDNF is involved as a modulator of morphine withdrawal symptoms, increasing locomotor sensitization, for instance [37] . Consistently with these findings, we have shown that similar treatment with morphine induces some exploratory-like behaviour related to opioid withdrawal in the medium (P30) and long term (P60) (Rozisky et al., personal communication). There is evidence that chronic exposure to psychotropic drugs can lead to increased BDNF levels in mesolimbic system-related structures, such as the ventral tegmental area in rats [64] . Moreover, BDNF infusions in this structure dramatically enhance several behavioural effects of drugs, including psychomotor sensitization [64] .
Our group recently showed that this morphine treatment promotes a hyperalgesic response in the medium and long term (at P30 and P60), which was reverted by administration of an NMDA receptor antagonist [18] and behavioural sensitization in the short and medium term (at P16 and P30) (Rozisky et al., personal communication) . Thus, we can suggest that morphine treatment in early life could lead to increased BDNF levels in the hippocampus, associated with possible central sensitization in the medium and long term. Viewed as a whole, our findings suggest that BDNF could modulate withdrawal symptoms in the medium and long term after morphine exposure in early life, since this neurotrophin might operate as a modulator of synaptic transmission, and this could be a cellular correlate for information processing of withdrawal symptoms in the mammalian brain after exposure to opioids. The spontaneous withdrawal by cessation of morphine administration resulted in selective and specific neuronal and glial cell damage in the cerebral cortex, hippocampus, brainstem, thalamus and hypothalamus [11] [12] [13] [14] . Wan et al. [65] demonstrated that chronic morphine exposure leads to upregulation of BDNF mRNA and protein in areas associated with rewarding, such as the hippocampus. Yu et al. [66] showed that BDNF could protect neurons, and suppress morphine dependence and withdrawal formation by increasing BDNF gene expression in the hippocampus, locus coeruleus, and prefrontal cortex. In addition to these studies, spontaneous morphine withdrawal resulted in selective and specific neuronal and glial cell damage in hippocampus and in other structures related to nociceptive transmission and behavioral sensitization [67] [68] [69] .
In this study, we also observed a decrease in superoxide dismutase activity and SOD/GPx ratio after morphine treatment in early life, and only effects of age in other oxidative stress parameters. SOD is considered an important antioxidant enzyme that protects from the damage caused by superoxide radicals [70] . Imbalances in SOD activity and a decrease of the SOD/GPx ratio could lead to increased superoxide anion (O 2Á -) and a decrease of H 2 O 2 , and, thus, inhibition of production of the hydroxyl radical (OHÁ), through a reaction with iron or copper (Fenton chemistry) [71] , since this radical is the most powerful oxidant molecule. A previous study showed that morphineinduced superoxide production could occur as a result of activation of l-opioid receptors, leading to activation of the phospholipase D pathway, an increase in intracellular Ca 2? and generation of superoxide anion, which can elicit oxidative stress and apoptosis [72] . In addition, evidence suggests that SOD activity is decreased when cells or tissues undergo oxidative stress [73, 74] . Despite this effect on oxidative stress parameters, we observed no differences in cell damage or cell viability between the control and morphine groups when using hippocampal slices. However, when these slices were incubated with H 2 O 2, increased LDH release and MTT reduction was observed in both groups and at all three points in time (P16, P30 and P60) after morphine treatment. Nevertheless, further studies are required to ascertain whether morphine treatment in early life can promote neuronal death or plasticity in the medium and long term.
Additionally, studies have shown that neuroinflammation and expression of pro-inflammatory cytokines, such as TNF-a, are associated with development of morphine tolerance [75] , pain transmission and the generation of inflammatory and neuropathic pain [76] . Although these pro-inflammatory cytokines have been shown to be involved in modulation of morphine withdrawal symptoms, we found effects of age and of morphine treatment in hippocampal TNF-a levels. Thus, we suggest that repeated low doses of morphine in early life lead to changes in inflammatory processes in the hippocampus, and it can be related to BDNF changes after morphine withdrawal.
The limitation of the animal studies concerns the potential for their results to be translated. For instance, all experiments in this study were conducted in male rats, complicating the translation of the results to both genders in humans, particularly because the nociceptive process is altered by modulations in hormone state [38] . Our limitations also could be related to it was not evaluated the binding and expression of receptors, this will be the next step of study.
In conclusion, our findings show that repeated morphine treatment in the neonatal period can lead to long-lasting neurochemical changes in the hippocampus of male rats, as demonstrated by increased BDNF levels in the medium and long term and inhibition of SOD activity and decreased SOD/GPx ratio in the long term. Thus, this study indicates the importance of knowledge of cellular and intracellular adaptations that occur in the hippocampus after opioid exposure in early life and the potential importance of these adaptations to withdrawal. In addition, this knowledge may prove beneficial in limiting the side effects of morphine in clinical practice and in the development of strategies for treatment and prevention of opioid addiction after exposure in the neonatal period.
